Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut-lung axis and dysbiosis in COVID-19
Büşra Aktaş, Belma Aslım
TURKISH JOURNAL OF BIOLOGY (2020) Vol. 44, Iss. 3, pp. 265-272
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
Yushun Wan, Jian Shang, Rachel L. Graham, et al.
Journal of Virology (2020) Vol. 94, Iss. 7
Open Access | Times Cited: 4545
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Jinjin Zhang, Xiang Dong, Yiyuan Cao, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1730-1741
Open Access | Times Cited: 4089
SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role
Ahmad Ud Din, Maryam Mazhar, Muhammad Waseem, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110947-110947
Open Access | Times Cited: 113
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 60
The human gut virome: composition, colonization, interactions, and impacts on human health
Evan Pargin, Michael J. Roach, Amber Skye, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 31
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions
Ludmila Müller, Svetlana Di Benedetto
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
Larissa Braga Costa, Lucas Giandoni Perez, Vitória Andrade Palmeira, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 67
Altered gut microbial metabolites could mediate the effects of risk factors in Covid‐19
Jiezhong Chen, Sean Hall, Luis Vitetta
Reviews in Medical Virology (2021) Vol. 31, Iss. 5, pp. 1-13
Open Access | Times Cited: 52
Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
Piero Sestili, Carmela Fimognari
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 51
Interplay of Good Bacteria and Central Nervous System: Cognitive Aspects and Mechanistic Considerations
Mahmoud Salami
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 49
SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Indranil Chattopadhyay, Esaki M. Shankar
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 44
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
Geetika Verma, Manish Dhawan, AbdulRahman A. Saied, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 18
Post-infection functional gastrointestinal disorders following coronavirus disease-19: a prospective follow-up cohort study
Daya Zhang, Chen Chen, Yunqian Xie, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID‐19 patients: A randomized placebo‐controlled trial
Mahsa Vaezi, Sahar Ravanshad, Mina Akbari Rad, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 16
Intestinal Barrier Function in Health and Disease—Any Role of SARS-CoV-2?
Lakshya Sharma, Antonio Riva
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1744-1744
Open Access | Times Cited: 41
Immunomodulatory Role of Nutrients: How Can Pulmonary Dysfunctions Improve?
Sarah Cristina Gozzi-Silva, Franciane Mouradian Emidio Teixeira, Alberto José da Silva Duarte, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 40
Potential Associations Between Microbiome and COVID-19
Huifen Wang, Haiyu Wang, Ying Sun, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34
Coronavirus disease 2019 and the gut–lung axis
Dan Dan Zhou, Qiu Wang, Hanmin Liu
International Journal of Infectious Diseases (2021) Vol. 113, pp. 300-307
Open Access | Times Cited: 33
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 25, pp. 2802-2822
Open Access | Times Cited: 26
Calprotectin: The Link Between Acute Lung Injury and Gastrointestinal Injury in Covid-19: Ban or Boon
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Protein and Peptide Science (2022) Vol. 23, Iss. 5, pp. 310-320
Closed Access | Times Cited: 23
Candida in COVID-19: Gut-Lung Axis, Dysbiosis, and Infections
Milena Kordalewska, David S. Perlin
Current Fungal Infection Reports (2023)
Open Access | Times Cited: 13
Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission
Hafez Al-Momani, Andrew Nelson, Hadeel Al Balawi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19
Zirui Meng, Shuo Guo, Yanbing Zhou, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 31
COVID-19 and Dentistry in 72 Questions: An Overview of the Literature
Stéphane Derruau, Jérôme Bouchet, Ali Nassif, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 779-779
Open Access | Times Cited: 30
Intestinal Microbiota—A Promising Target for Antiviral Therapy?
Mengling Yang, Yang Yang, Qingnan He, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top